Regulation of the Complement Receptor Type 2 (CR2/CD21) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus.

StatusFinished
Effective start/end date1/01/0431/12/04

Funding

  • Arthritis Foundation of WA